Consulting Firm Hires Senior Leader Within Biopharmaceutical Practice –
October 28, 2016 – Raleigh-Durham, N.C. – Kineticos, a specialized strategy consulting firm serving the life sciences industry, today announced the expansion of its Biopharmaceutical practice leadership team with the addition of Glen Martin, Senior Vice President.
Glen Martin joins Kineticos as a seasoned executive with more than 22 years of experience in the biopharmaceutical industry. Mr. Martin held roles in sales for several start up biopharma companies before moving to Pharmion, a then-leading global oncology company. While at Pharmion, Mr. Martin held various management roles in sales before moving to Medical Affairs and becoming the National Director of the US Medical Science Liaison program. After Pharmion was acquired by Celgene in 2008, Glen took on responsibilities as Celgene’s Senior Director, Outcomes Research & Operations. Subsequently, Glen spent 4 years serving in the capacity of Chief of Staff for Celgene’s US Medical Affairs group before being recruited by Covis Pharma, a unique start up company, to serve as Vice President of Oncology Sales. Following the acquisition of Covis, Mr. Martin served as Senior Vice President, Medical Sciences for Ashfield Healthcare. Mr. Martin earned his BA in Psychology from LaSalle University in Philadelphia, PA.
“Glen adds extensive cross-functional experience to the practice along with an impressive track record of bringing new biopharmaceutical products to market with a focus on oncology,” stated Founder and CEO of Kineticos, Shailesh Maingi. “Our clients are the heart of our entrepreneurial consulting practice. Glen’s expertise adds depth to our existing consulting capabilities, especially in oncology which constitutes 40% of all active clinical trials, and adds more resources to our practice as an increasing number of biopharma clients depend on our team to guide their path to market,” he continued.
About the Biopharmaceutical Practice at Kineticos
The Biopharmaceutical practice at Kineticos assists growth-oriented pharmaceutical and biotech companies realize their commercial potential at the corporate, portfolio and product levels. The firm’s consulting team members have a depth of expertise across functional areas and therapeutic areas, established through decades of work in consulting and in industry. Overall, the practice has a strong commitment to client satisfaction and a proven ability to deliver results through practical solutions. The Biopharmaceutical practice at Kineticos supports clients across three service areas including corporate strategy & development, medical affairs strategy and commercial strategy. For more information on the Biopharmaceutical practice at Kineticos, please visit http://www.kineticos.com/life-science-consulting-companies/biopharmaceutical-practice/.
Kineticos is a specialized strategy consulting firm serving the life science industry.
At Kineticos, we have a simple mission: to help our sponsors solve their most complex problems. We work exclusively within the life sciences ecosystem. And our focus is strategy, business development & licensing, market access, innovation and operational excellence. Our values start with an entrepreneurial culture focused on exceptional outcomes for our sponsors through deep engagements. We foster an environment where our business and life science experts can be creative, critical and collaborative thinkers. We value context and transparency over hierarchy and control. We do all of this to improve patient outcomes, our shared purpose with our sponsors.